Literature DB >> 1810606

Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.

D P Brooks1, L C Contino, B Storer, E H Ohlstein.   

Abstract

1. Six weeks following partial nephrectomy in rats, significant increases in serum urea nitrogen and serum creatinine concentration and a significant decrease in creatinine clearance were observed. 2. Measurement of systolic blood pressure by tail plethysmography indicated that animals that had undergone partial nephrectomy were hypertensive. 3. Compared to sham-operated animals, there were 4 fold increases in both urinary protein excretion and urinary endothelin excretion. 4. There was a significant correlation between urinary protein and urinary endothelin excretion (r = 0.77). There was also a correlation (r = 0.65) between urinary endothelin excretion and systolic blood pressure. 5. Plasma endothelin concentrations were not different in sham-operated and partially nephrectomized rats. 6. The data indicate that there is an increased renal endothelin production in rats with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1810606      PMCID: PMC1908829          DOI: 10.1111/j.1476-5381.1991.tb12537.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Endothelin stimulates PDGF secretion in cultured human mesangial cells.

Authors:  F E Jaffer; T C Knauss; E Poptic; H E Abboud
Journal:  Kidney Int       Date:  1990-12       Impact factor: 10.612

2.  Synthesis of the vasoconstrictor peptide endothelin in kidney cells.

Authors:  T Kosaka; N Suzuki; H Matsumoto; Y Itoh; T Yasuhara; H Onda; M Fujino
Journal:  FEBS Lett       Date:  1989-05-22       Impact factor: 4.124

3.  Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.

Authors:  M S Simonson; S Wann; P Mené; G R Dubyak; M Kester; Y Nakazato; J R Sedor; M J Dunn
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Renal microvascular effects of endothelin.

Authors:  R M Edwards; W Trizna; E H Ohlstein
Journal:  Am J Physiol       Date:  1990-08

6.  Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line.

Authors:  K Ohta; Y Hirata; T Imai; K Kanno; T Emori; M Shichiri; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1990-06-15       Impact factor: 3.575

7.  Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

8.  Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis.

Authors:  Y Yoshida; A Fogo; I Ichikawa
Journal:  Kidney Int       Date:  1989-02       Impact factor: 10.612

9.  Endothelin: a potent renal and systemic vasoconstrictor peptide.

Authors:  A J King; B M Brenner; S Anderson
Journal:  Am J Physiol       Date:  1989-06

10.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Authors:  S Anderson; T W Meyer; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

View more
  3 in total

1.  Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

Authors:  D P Brooks; B G Short; M J Cyronak; L C Contino; M DiCristo; Y X Wang; R R Ruffolo
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

2.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.

Authors:  J P Cristol; T D Warner; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  Endothelin-1, big endothelin-1, and nitric oxide in patients with chronic renal disease and hypertension.

Authors:  Ivanka Mikulić; József Petrik; Kresimir Galesić; Zeljko Romić; Ivana Cepelak; Monika Zeljko-Tomić
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.